Invikafusp alfa

AssetAlso called invika

Activates selected T cells through T-cell receptor binding and interleukin-2 signaling.

Stage
Phase 2
Modality
Protein or enzyme
Target
Not known
11
Indications
0
Trials
1
Developer

Named in the news on Oct 23, 2026. medicalxpress.com

Indications

11

8 more

In the full profile

  • Owner and partners1
  • Competitors12

Every asset’s record: target, stage, trials and the evidence behind it.

See Pro

Assets